Found: 2
Select item for more details and to access through your institution.
High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose.
- Published in:
- 2002
- By:
- Publication type:
- journal article
High-dose CD34+cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose.
- Published in:
- Transfusion, 2002, v. 42, n. 4, p. 443, doi. 10.1046/j.1525-1438.2002.00060.x
- By:
- Publication type:
- Article